Assessment of genomic imbalances in malignant fibrous histiocytomas by comparative genomic hybridization

International Journal of Molecular Medicine

Volumn 3, Issue 1, 1999, Pages 75-79

  Hinze, Raoul ^a   Schagdarsurengin, Undraga ^a   Taubert, Helge ^a   Meye, Axel ^a   Würl, Peter ^b   Holzhausen, Hans Jürgen ^a   Rath, Friedrich Wilhelm ^a   Schmidt, Hannelore ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Amplification 12q13 15; CGH; Cytogenetics; Malignant fibrous histiocytoma

Indexed keywords

ANEUPLOIDY; ARTICLE; AUTOSOME; CHROMOSOME ABERRATION; DERMATOFIBROMA; FEMALE; GENETICS; HUMAN; HUMAN CHROMOSOME; IN SITU HYBRIDIZATION; MALE; METHODOLOGY; PATHOLOGY;

ANEUPLOIDY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, 1-3; CHROMOSOMES, HUMAN, 13-15; CHROMOSOMES, HUMAN, 16-18; CHROMOSOMES, HUMAN, 19-20; CHROMOSOMES, HUMAN, 4-5; CHROMOSOMES, HUMAN, 6-12 AND X; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IN SITU HYBRIDIZATION; MALE;

EID: 0032608227     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.3.1.75     Document Type: Article

References (30)

1. Enzinger FM and Weiss SW: Soft Tissue Tumors. 3rd edition. St. Louis, MO, Mosby, 1995.
2. Mandahl N, Heim S, Willen H, Rydholm A, Eneroth M, Nilberg M, Kreicbergs A and Mitelman F: Characteristic karyotypic anomalies identify sybtypes of malignant fibrous histiocytomas. Genes Chromosomes Cancer 1:9-14, 1989.
3. + marker chromosome have increased relapse rate. Genes Chromosomes Cancer 2: 296-299, 1990.
4. Schmidt H, Körbcr S, Hinze R, Taubcrt H, Meye A, Würl P, Holzhausen H-J, Dralle H and Rath F-W: Cytogenctic characterization of ten malignant fibrous histiocytomas. Cancer Genet Cytogcnet 100: 134-142, 1998.
5. Fletcher JA: Cytogcnctics and molecular biology of soft tissue tumors. Monogr Pathol 38: 37-64, 1996.
6. Ozaki T, Ikcda S, Kawai A, Inoue H and Oda T: Alterations of retinoblastoma susceptible gene accompanied by c-myc amplification in human bone and soft tissue tumors. Cell Mol Biol 39: 235-242, 1993.
7. Taubert H, Würl P, Meye A, Berger D, Thamm B, Neumann K, Hinze R, Schmidt H and Rath F-W: Molecular and immunohistochemical p53 status in liposarcoma and malignant fibrous histiocytoma. Cancer 76: 1187-1196, 1995.
8. Reid AH, Tsai MS, Venzon DJ, Wright CF, Lack EE and O'Leary TJ: MDM2 amplification, p53 mutation, and accumulation of the p53 gene product in malignant fibrous histiocytoma. Diagn Mol Pathol 5: 65-73, 1996.
9. INK4A/CDKN2/MTS l mutations independently of p53 status in soft tissue sarcomas. J Pathol 184: 14-17,1998.
10. Choong PFM, Mandahl N, Mertens F, Willen H, Mitelman F and Rydholm A: 19p+ marker chromosome correlates with relapse rate in malignant fibrous histiocytoma. Genes Chromosomes Cancer 16: 88-93,1996.
11. Knuutila S, Bjorkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V and Zhu Y: DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 152: 1107-1123, 1998.
12. Van Unnik JAM, Coindre JM, Contesso G, Albus-Luttcr CE, Schiodt T and Garcia-Miralles T: Grading of soft tissue sarcomas. In: Experience of the EORTC Soft Tissue and Bone Sarcoma Treatment. Ryan JR and Baker LO (eds). Kluwer Academic Publishers, Dordrecht, pp7-13, 1988.
13. Schmidt H, Körber S, Hinze R, Taubert H, Meye A, Würl P, Bache M, Holzhausen H-J, Dralle H and Rath F-W: Detection of numerical chromosomal changes in 20 malignant fibrous Jiistiocytoma by FISH. Int J Oncol 12: 395-402, 1998.
14. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243,1994.
15. Forus A, Wcghuis DO, Smects D, Fodstad O, Myklebost O and van Kessel AG: Comparative genomic hybridization analysis of human sarcomas: I. Occurrence of genomic imbalances and identification of a novel major amplicon at Iq21-q22 in soft tissue sarcomas. Genes Chromosomes Cancer 14: 8-14, 1995.
16. Larramendy ML, Tarkkanen M, Blomqvist C, Virolainen M, Wiklund T, Asko-Seljavaara S, Elomaa I and Knuutila S: Comparative genomic hybridization of malignant fibrous histiocytoma reveals a novel prognostic marker. Am J Pathol 151: 1153-1161,1997.
17. Forus A, Weghuis DO, Smeets D, Fodstad O, Myklebost O and van Kessel AG: Comparative genomic hybridization analysis of human sarcomas: II. Identification of novel amplicons at 6p and 17p in osteosarcoma. Genes Chromosomes Cancer 14: 15-21, 1995.
18. Weber-Hall S, Anderson J, McManus A, Abc S, Nojima T and Pinkcrton R: Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 56: 3220-3224, 1996.
19. Schröck E, Thiel G, Lozanova T, Du Manoir S, Meffert M-C, Jauch A, Speicher MR, Nudie;rnberg P, Vogel S, Jänisch W, Donis-Keller H, Ried T, Witkowski R and Cremer T: Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal sains and losses. Am J Pathol 144: 1203-1218, 1994.
20. Ried T, Knutzen R, Steinbeck R, Biegen H, Schock E, Hcselmeyer K, Du Manoir S and Aucr G: Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15: 234-245, 1996.
21. Mitelman F: Catalog of chromosome aberrations in cancer. 5th edition. Wiley-Liss, New York, 1994.
22. Smith S, Wciss S, Jankowski SA, Coccia MA and Mcltzer PS: SAS amplification in soft tissue sarcomas. Cancer Res 52: 3746-3749, 1992.
23. Forus A, Florenes VA, Maelandsmo GM, Meltzer PS, Fodstad O and Myklebost O: Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Growth Differ 4: 1065-1070, 1993.
24. Khatib ZA, Matsushime H, Valentine M, Shapiro DN, Sherr CJ and Look AT: Coamplification of the CDK4 gene with mdm2 and GLI in human sarcomas. Cancer Res 53: 5535-5541, 1993.
25. Nilbert M, Rydholm A, Mitelman F, Meltzer PS and Mandahl N: Characterization of the 12ql3-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet 83: 32-36, 1995.
26. Mrelandsmo GM, Berner JM, Florenes FA, Forus A, Hovig E, Fodstad O and Myklebost O: Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas relationship to amplification and mRNA levels of CDK4 and CCNDl.BrJ Cancer 72: 393-398, 1995.
27. Palmer JL, Masui S, Pritchard S, Kalousek DK and Sorensen PH: Cytogenetic and molecular genetic analysis of a pediatrie pleomorphic sarcoma reveals similarities to adult malignant fibrous histiocytoma. Cancer Genet Cytogenet 95: 141-147, 1997.
28. Szymanska J, Mandahl N, Mertens F, Tarkkanen M, Karaharju E and Knuutila S: Ring chromosomes in parosteal osteosarcoma contain sequences from 12ql3-15: a combined cytogcnetic and comparative genomic hybridization study. Genes Chromosomes Cancer 16: 31-34, 1996.
29. Isola J, Kallioniemi OP, Chu LW, Fugua SAW, Hilsenbech SG, Osborne CK and Waldman FM: Genetic aberrations detected by CGH predict outcome in node-negative breast cancer. Am J Pathol 147:905-911, 1995.
30. Cordon-Cardo C, Latres E, Drobnjak M, Oliva M, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF and Levine A: Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 54: 794-799, 1994.